Mostrando resultados 1 a 20 de 215
Siguiente >
Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
closedAccess | | 2013 | A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers | Morancho, B.; Pandiella, Atanasio CSIC ORCID CVN ; Arribas, Joaquín | artículo |
closedAccess | | 2011 | A modular approach to trim cellular targets in anticancer drug discovery | Ríos-Luci, Carla; Díaz-Rodríguez, Elena CSIC ORCID CVN; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess | | 18-dic-2019 | A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors | Pérez-Peña, Javier; Tibor Fekete, Janos; Páez, Raquel; Baliu-Piqué, Mariona; García-Saenz, José Ángel; García-Barberán, Vanesa; Manzano, Aranzazu CSIC ORCID ; Pérez-Segura, Pedro; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Győrffy, Balázs; Ocaña, Alberto | artículo |
closedAccess | | 2005 | Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin | Yuste, Laura CSIC; Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess | | 2014 | Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis | Ocaña, Alberto; Cuenca-López, María D.; Seruga, Bostjan; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan | artículo |
closedAccess | | 2012 | Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer | Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID ; Re-Louhau, M. F. CSIC; Seoane, Samuel CSIC ORCID; Abad, María del Mar; Calero, R.; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess | | 30-ago-2019 | Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer | Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Alberto | artículo |
closedAccess | | 2020 | Adaptive resistance to trastuzumab impairs response to neratinib and lapatinib through deregulation of cell death mechanisms | Ríos-Luci, Carla; Díaz-Rodríguez, Elena CSIC ORCID CVN; Gandullo-Sánchez, Lucía CSIC ORCID; Díaz-Gil, Laura CSIC; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess | | 23-mar-2022 | Additional file 1 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset] | Montero, Juan Carlos CSIC ORCID; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | dataset |
openAccess | | 23-mar-2022 | Additional file 2 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset] | Montero, Juan Carlos CSIC ORCID; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | dataset |
openAccess | | 23-mar-2022 | Additional file 3 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset] | Montero, Juan Carlos CSIC ORCID; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | dataset |
openAccess | | oct-2020 | Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine | Fuentes-Antrás, Jesús; Guevara-Hoyer, Kissy; Baliu-Piqué, Mariona; García-Saenz, José Ángel; Pérez-Segura, Pedro; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo de revisión |
closedAccess | | 17-may-2018 | Alteraciones transcripcionales en la vía de la ubiquitina-proteasoma (UPP) de células HER2+ resistentes a trastuzumab | Orive-Ramos, Ana CSIC; Pérez-Peña, Javier; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | comunicación de congreso |
openAccess | | 2021 | Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma | García-Alonso, Sara; Romero-Pérez, Inés; Gandullo-Sánchez, Lucía CSIC ORCID; Chinchilla, Luis; Ocaña, Alberto; Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess | | 2023 | An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer | Montero, Juan Carlos CSIC ORCID; Carmen, Sofía del; Abad, Mar; Sayagués, José María CSIC ORCID ; Barbáchano, Antonio CSIC ORCID; Fernández-Barral, Asunción CSIC ORCID; Muñoz, Alberto CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess | | 1-feb-2023 | An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs | Gandullo-Sánchez, Lucía CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
openAccess | | 2020 | An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy | Juan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto; Alonso-Moreno, Carlos | artículo |
openAccess | | 2012 | Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands | Carrión-Salip, Dolors; Pandiella, Atanasio CSIC ORCID CVN ; Massaguer, Anna | artículo |
openAccess | | 21-ago-2020 | Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment | Juan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto; Alonso, Carlos CSIC | artículo |
closedAccess | | 2016 | Antiproliferative effect of Synadenium grantii Hook f. stems (Euphorbiaceae) and a rare phorbol diterpene ester | Campos, Adriana; Barbosa Vendramini-Costa, Débora; Barbarini Longato, Giovanna; Tailyn Zermiani, Ana; Tasca Gois Ruiz, Lúcia; Carvalho, João Ernesto de; Pandiella, Atanasio CSIC ORCID CVN ; Cechinel Filho, Valdir | artículo |